Literature DB >> 1204254

Anti-reticulin antibody in jejunal juice in coeliac disease.

H Mawhinney, A H Love.   

Abstract

Anti-reticulin antibody has been demonstrated in the jejunal juice of eight out of fourteen (57%) untreated coeliac patients, one out of twelve (8%) patients with normal jejunal biopsies and none of ten normal control subjects. The jejunal juice antibody was invariably of the IgA class. It is suggested that the presence of anti-reticulin antibody in the jejunal juice in coeliac disease supports the hypothesis that this antibody is secreted in response to reticulin antigens present in the diet.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1204254      PMCID： PMC1538310     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  15 in total

1.  Ultra-rapid fluorescent labelling of proteins.

Authors:  H RINDERKNECHT
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

2.  The use of cord serum and indirect viral immunofluorescence as a method of evaluating the immunological specificity of fluorescein-labelled anti-human IgA conjugate.

Authors:  H Mawhinney; M Haire; B M Adair
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

3.  Reticulin antibody in children with malabsorption.

Authors:  R von Essen; E Savilahti; P Pelkonen
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

4.  Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease.

Authors:  P P Seah; L Fry; J S Stewart; B L Chapman; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1972-03-18       Impact factor: 79.321

5.  Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease, and their relation to immunoglobulins and dietary antibodies.

Authors:  M H Alp; R Wright
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

6.  Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

7.  Influenza antibody response following aerosal administration of inactivated virus.

Authors:  R H Waldman; S H Wood; E J Torres; P A Small
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

8.  Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children.

Authors:  A Ferguson; F Carswell
Journal:  Br Med J       Date:  1972-01-08

9.  Immunoglobulins and dietary protein antibodies in childhood coeliac disease.

Authors:  K G Kenrick; J A Walker-Smith
Journal:  Gut       Date:  1970-08       Impact factor: 23.059

10.  GAMMA-GLOBULINS: QUANTITATIVE RELATIONSHIPS IN HUMAN SERUM AND NONVASCULAR FLUIDS.

Authors:  W B CHODIRKER; T B TOMASI
Journal:  Science       Date:  1963-11-22       Impact factor: 47.728
View more
  10 in total

1.  Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.

Authors:  A Tosco; R Aitoro; R Auricchio; D Ponticelli; E Miele; F Paparo; L Greco; R Troncone; M Maglio
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

2.  Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.

Authors:  A Tosco; R Auricchio; R Aitoro; D Ponticelli; M Primario; E Miele; V Rotondi Aufiero; V Discepolo; L Greco; R Troncone; M Maglio
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

3.  IgA and IgG reticulin antibodies in coeliac and non-coeliac patients.

Authors:  O E Eade; R S Lloyd; C Lang; R Wright
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.

Authors:  T Rauhavirta; S-W Qiao; Z Jiang; E Myrsky; J Loponen; I R Korponay-Szabó; H Salovaara; J A Garcia-Horsman; J Venäläinen; P T Männistö; R Collighan; A Mongeot; M Griffin; M Mäki; K Kaukinen; K Lindfors
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

5.  Jejunal villous changes associated with farmer's lung.

Authors:  T J Robinson; S D Nelson; M Haire; D Middleton; S A McMillan; J P Evans
Journal:  Postgrad Med J       Date:  1981-11       Impact factor: 2.401

6.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Authors:  I R Korponay-Szabó; T Halttunen; Z Szalai; K Laurila; R Király; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques.

Authors:  Kaushiki Mazumdar; Xavier Alvarez; Juan T Borda; Jason Dufour; Edith Martin; Michael T Bethune; Chaitan Khosla; Karol Sestak
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

8.  Hyposplenism, adult coeliac disease, and autoimmunity.

Authors:  A W Bullen; R Hall; G Gowland; S Rajah; M S Losowsky
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

9.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

Review 10.  Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.

Authors:  Mariantonia Maglio; Riccardo Troncone
Journal:  Front Nutr       Date:  2020-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.